KLOW Blend Peptide – User Manual & Dosage Protocol Guide
Product Overview
KLOW Blend Peptide is a proprietary peptide formulation designed to support skin hydration, anti-aging, and cellular rejuvenation. It is commonly used experimentally to:
- Promote skin elasticity and firmness
- Reduce the appearance of fine lines and wrinkles
- Support collagen and elastin synthesis
- Enhance cellular repair and regeneration
Disclaimer: KLOW Blend Peptide is for research and experimental use only. It is not FDA-approved for cosmetic or medical purposes. Consult a qualified healthcare professional before use.
Forms Available
Lyophilized Powder
- Freeze-dried peptide blend for reconstitution
Injection Solution
- Subcutaneous (SC) or intramuscular (IM) solution after reconstitution
Oral/Topical (if included)
- Daily administration; bioavailability may be limited
Mechanism of Action
KLOW Blend Peptide contains a synergistic mixture of peptides that may:
- Stimulate collagen and elastin production in skin tissue
- Promote cellular repair and regeneration
- Improve skin hydration, texture, and tone
- Provide antioxidant and anti-aging support
Effects are primarily observed in research settings and limited human trials.
Dosage Protocol (Investigational)
Administration
Subcutaneous (SC) Injection
- Typical Dose: 2–5 mg
- Frequency: 2–3× per week
- Notes: Inject near target areas for localized effect
Intramuscular (IM) Injection
- Typical Dose: 2–5 mg
- Frequency: 1–2× per week
- Notes: Systemic or local injection possible
Oral/Topical (if included)
- Typical Dose: 250–500 mg
- Frequency: Daily
- Notes: Slower effect due to digestion and absorption
Cycle Protocol (Investigational)
Initial Phase
- Duration: 2–4 weeks
- Dose: 2 mg SC/IM, 2× per week
- Notes: Assess tolerance and initial response
Therapeutic Phase
- Duration: 4–8 weeks
- Dose: 3–5 mg SC/IM, 2–3× per week
- Notes: Optimal effect on skin rejuvenation
Rest Period
- Duration: 1–2 months
- Dose: None
- Notes: Allows skin and tissue to reset before the next cycle
Total cycles per year typically range from 2–4 cycles, depending on research goals.
Reconstitution Instructions (Lyophilized Powder)
Supplies Needed:
- Sterile bacteriostatic water
- Sterile syringe
- Alcohol swabs
Steps:
- Clean vial top with alcohol swab.
- Add the desired volume of bacteriostatic water (e.g., 10 mg peptide + 2 mL water → 5 mg/mL solution).
- Swirl gently to dissolve; do not shake.
- Store reconstituted solution refrigerated (2–8°C).
Use within 2–4 weeks; discard if cloudy or discolored.
Administration Guidelines
Subcutaneous Injection (SC)
- Select clean injection site near areas of concern (face, neck, arms).
- Clean site with alcohol swab.
- Insert needle at 45° angle.
- Inject slowly; apply gentle pressure afterward.
- Rotate injection sites to avoid tissue irritation.
Intramuscular Injection (IM)
- Select clean muscle site (deltoid, glute, thigh).
- Clean site with alcohol swab.
- Insert needle at 90° angle and inject slowly.
- Apply gentle pressure afterward.
Tip: SC injections near skin-targeted areas may provide more visible results.
Storage Guidelines
Storage Information
Lyophilized Powder
- Storage: Cool, dry place
- Shelf Life: Up to 12 months
Reconstituted Solution
- Storage: Refrigerate at 2–8°C
- Shelf Life: 2–4 weeks
Oral/Topical
- Storage: Room temperature, dry place
- Shelf Life: 12 months
Important:
Discard the solution if it becomes cloudy, discolored, or contains particulates.
Safety & Precautions
- Not for pregnant or breastfeeding women
- Avoid if allergic to peptides
- Mild side effects may include irritation at injection site or redness
- Discontinue if severe adverse reactions occur
- Keep out of reach of children
Effects in humans are primarily investigational.
Quick Reference Cycle Chart (Investigational)
Weekly Cycle Schedule
Week 1–2
- Dose: 2 mg SC/IM, 2× per week
- Notes: Initial tolerance phase
Week 3–4
- Dose: 3 mg SC/IM, 2–3× per week
- Notes: Therapeutic dose escalation
Week 5–8
- Dose: 5 mg SC/IM, 2–3× per week
- Notes: Full therapeutic cycle
Week 9+
- Dose: Rest
- Notes: 1–2 month break before the next cycle
Visual Guide
- Diagrams of SC and IM injection sites (facial, neck, arm, thigh, deltoid)
- Step-by-step reconstitution guide
- Safety icons for handling, storage, and injections